Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)-Reference-Cited by-同舟云学术

Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)

Published:2023-01 Issue: Volume:Volume 19 Page:57-65
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Fagiuoli Stefano^ORCID,Toniutto Pierluigi^ORCID,Coppola Nicola^ORCID,Ancona Domenica Daniela,Andretta Margherita,Bartolini Fausto,Ferrante Fulvio,Lupi Alessandro^ORCID,Palcic Stefano,Rizzi Francesca Vittoria,Re Davide,Alvarez Nieto Gema,Hernandez Candido,Frigerio Francesca,Perrone Valentina,Degli Esposti Luca^ORCID,Mangia Alessandra^ORCID

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Reference25 articles.

1. Hepatitis C cirrhosis: New perspectives for diagnosis and treatment

2. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. World Health Organization; 2016. Available from: https://apps.who.int/iris/handle/10665/246177. Accessed January 5, 2023.

3. Estimation of the number of HCV-positive patients in Italy

4. Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis

5. Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis;Therapeutics and Clinical Risk Management;2023-08